← Back to Search

mindfulness-based therapy for Depression (ARG Trial)

N/A
Waitlist Available
Led By Angela N Bowen, PhD
Research Sponsored by University of Saskatchewan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
15 to 28 weeks pregnant and English speaking
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will be asked to complete the questionnaires before the group commences, at 4 weeks, at the end of the group, and 6 weeks postpartum.
Awards & highlights

ARG Trial Summary

Approximately 20% of pregnant women experience depression. Untreated depression during pregnancy is linked to decreased prenatal care, difficulties in the pregnancy, poorer outcomes for the baby, and developmental, language, and behaviour problems in the older child. While medication can often offer relief, pregnant women suffering with depression are often reluctant to take medications that may affect the unborn baby. There is little research about the effectiveness of other treatments such as support groups. The investigators project will provide relaxation groups for pregnant women with anxiety and depression. The group will provide a chance to get support from other pregnant women. Two health care specialists will provide information about anxiety and depression. They will also teach the skills for women to manage their symptoms. Women will be asked to complete a few questionnaires to evaluate their symptoms before, during, and after they join the group. They will also be asked to evaluate how the group met their needs.

Eligible Conditions
  • Depression
  • Anxiety

ARG Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

ARG Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be asked to complete the questionnaires before the group commences, at 4 weeks, at the end of the group, and 6 weeks postpartum.
This trial's timeline: 3 weeks for screening, Varies for treatment, and participants will be asked to complete the questionnaires before the group commences, at 4 weeks, at the end of the group, and 6 weeks postpartum. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depression as measured by Edinburgh Postnatal Depression Scale and anxiety as measured by the State-Trait Anxiety Inventory and the Cambridge Worry Scale

ARG Trial Design

2Treatment groups
Experimental Treatment
Group I: mindfulness-based therapyExperimental Treatment1 Intervention
mindfulness-based meditation
Group II: interpersonal therapyExperimental Treatment1 Intervention
psycho-educational

Find a Location

Who is running the clinical trial?

University of SaskatchewanLead Sponsor
251 Previous Clinical Trials
154,390 Total Patients Enrolled
7 Trials studying Depression
2,308 Patients Enrolled for Depression
Royal University Hospital Foundation, Saskatoon, SK, CanadaUNKNOWN
Angela N Bowen, PhDPrincipal InvestigatorUniversity of Saskatchewan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025